CoreCap Advisors’s Core Laboratories CLB Stock Holding History

CoreCap Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18	Closed	-$270	–	2855
2025 Q1	$270	Buy	+18	New	+$301	﹤0.01%	2842

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CoreCap Advisors's CLB Position: Q2 2025 in Review

CoreCap Advisors sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 18 shares — an estimated $270 sold.

CoreCap Advisors first reported a position in CLB in Q1 2025 and held it in 1 quarter. The position peaked at $270 in Q1 2025. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

CoreCap Advisors reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
CoreCap Advisors sold 18 Core Laboratories shares in Q2 2025, an estimated $270.
CoreCap Advisors first reported a position in Core Laboratories in Q1 2025 and held it in 1 quarter.
CoreCap Advisors's Core Laboratories position peaked at $270 in Q1 2025.
191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.